Literature DB >> 6448165

Serotoninergic modulation of mesolimbic and frontal cortical dopamine neurons.

P C Waldmeier.   

Abstract

Potentiation of the effect of haloperidol on dopamine metabolism by the 5-HT uptake inhibitor CGP 6085 A, and antagonism of this effect by the 5-HT antagonist mianserin were observed in the mesolimbic area and the frontal cortex of the rat brain. A similar effect was reported earlier in the corpus striatum. This suggests that serotoninergic modulation of dopamine neurons is a generally-occurring phenomenon in the brain.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6448165     DOI： 10.1007/bf01965988

Source DB:  PubMed          Journal:  Experientia        ISSN： 0014-4754


  25 in total

Review 1.  Interactions between serotonergic and catecholaminergic systems in the brain.

Authors:  W Kostowski
Journal:  Pol J Pharmacol Pharm       Date:  1975-10

Review 2.  The serotonergic system in the brain and its possible functional connections with other aminergic systems.

Authors:  R Samanin; S Garattini
Journal:  Life Sci       Date:  1975-10-15       Impact factor: 5.037

3.  Determination of homovanillic acid in urine by liquid chromatography with electrochemical detection.

Authors:  L J Felice; P T Kissinger
Journal:  Anal Chem       Date:  1976-05       Impact factor: 6.986

4.  Blockade of presynaptic alpha-receptors and of amine uptake in the rat brain by the antidepressant mianserine.

Authors:  P A Baumann; L Maître
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-10       Impact factor: 3.000

5.  Reduced cataleptogenic effects of some neuroleptics in rats with lesioned midbrain raphe and treated with p-chlorophenylalanine.

Authors:  W Kostowski; W Gumulka; A Cxlonkowski
Journal:  Brain Res       Date:  1972-12-24       Impact factor: 3.252

6.  Central dopaminergic neurons: effects of alterations in impulse flow on the accumulation of dihydroxyphenylacetic acid.

Authors:  R H Roth; L C Murrin; J R Walters
Journal:  Eur J Pharmacol       Date:  1976-03       Impact factor: 4.432

7.  Effect of drugs influencing central serotonergic mechanisms on haloperidol-induced catalepsy.

Authors:  J J Balsara; J H Jadhav; A G Chandorkar
Journal:  Psychopharmacology (Berl)       Date:  1979-03-29       Impact factor: 4.530

8.  Regional rat brain levels of 3,4-dihydroxyphenylacetic acid and homovanillic acid: concurrent fluorometric measurement and influence of drugs.

Authors:  B H Westerink; J Korf
Journal:  Eur J Pharmacol       Date:  1976-08       Impact factor: 4.432

9.  Serotonin--dopamine interactions in the nigrostriatal system.

Authors:  P C Waldmeier; A A Delini-Stula
Journal:  Eur J Pharmacol       Date:  1979-05-15       Impact factor: 4.432

10.  Selective inhibition of noradrenaline and serotonin uptake by C 49802-B-Ba and CGP 6085 A.

Authors:  P C Waldmeier; P A Baumann; M Wilhelm; R Bernasconi; L Maître
Journal:  Eur J Pharmacol       Date:  1977-12-15       Impact factor: 4.432
View more
  3 in total

1.  Modulation of dopaminergic transmission by alpha-noradrenergic agonists and antagonists: evidence for antidopaminergic properties of some alpha antagonists.

Authors:  P C Waldmeier; R Ortmann; S Bischoff
Journal:  Experientia       Date:  1982-10-15

2.  Effects of CGP 11305 A, a new reversible and selective inhibitor of MAO A, on biogenic amine levels and metabolism in the rat brain.

Authors:  P C Waldmeier; P A Baumann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-09       Impact factor: 3.000

3.  Clinical and biochemical effects of citalopram, a selective 5-HT reuptake inhibitor--a dose-response study in depressed patients.

Authors:  L Bjerkenstedt; G Edman; L Flyckt; L Hagenfeldt; G Sedvall; F A Wiesel
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.